ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,924,331 | +21.9% | 178,842 | -3.4% | 0.07% | +25.9% |
| Q2 2023 | $72,156,511 | -1.9% | 185,145 | -10.3% | 0.05% | -6.9% |
| Q1 2023 | $73,574,442 | -8.8% | 206,334 | -3.1% | 0.06% | -12.1% |
| Q4 2022 | $80,683,592 | +5.0% | 212,981 | -2.1% | 0.07% | -2.9% |
| Q3 2022 | $76,825,000 | -10.2% | 217,603 | -3.7% | 0.07% | -2.9% |
| Q2 2022 | $85,593,000 | +18.2% | 225,910 | -1.6% | 0.07% | +42.9% |
| Q1 2022 | $72,395,000 | -9.1% | 229,599 | +0.9% | 0.05% | -3.9% |
| Q4 2021 | $79,670,000 | +17.4% | 227,507 | +1.3% | 0.05% | +10.9% |
| Q3 2021 | $67,846,000 | -45.1% | 224,656 | -45.2% | 0.05% | -45.2% |
| Q2 2021 | $123,472,000 | +10.1% | 410,111 | +0.7% | 0.08% | +2.4% |
| Q1 2021 | $112,125,000 | -6.0% | 407,153 | +0.3% | 0.08% | -11.8% |
| Q4 2020 | $119,343,000 | +7.2% | 405,803 | -4.3% | 0.09% | -6.1% |
| Q3 2020 | $111,293,000 | +8.0% | 423,943 | -7.3% | 0.10% | +1.0% |
| Q2 2020 | $103,016,000 | +115.2% | 457,385 | +25.9% | 0.10% | +71.9% |
| Q1 2020 | $47,859,000 | -16.0% | 363,311 | +2.4% | 0.06% | +5.6% |
| Q4 2019 | $56,946,000 | +256.5% | 354,755 | +153.1% | 0.05% | +237.5% |
| Q3 2019 | $15,973,000 | +52.5% | 140,162 | +89.4% | 0.02% | +60.0% |
| Q2 2019 | $10,476,000 | – | 73,994 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |